Plasmablastic lymphoma (PBL) is an aggressive lymphoma commonly associated with HIV
infection. However, PBL can also be seen in patients with other immunodeficiencies as well …

Within weeks of the first report of acquired immunodeficiency syndrome (AIDS) in 1981, it
was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin …

Plasmablastic lymphoma (PBL) is an aggressive lymphoma characterized by a terminally
differentiated B-cell phenotype that usually occurs in the immunocompromised or elderly …

Epstein–Barr virus (EBV) is aetiologically linked to a wide range of human tumours. Some
arise as accidents of the virus' lifestyle in its natural niche, the B lymphoid system; these …

There have been several additions and deletions in Chapter 4 on Tumours of the oral cavity
and mobile tongue in the 2017 fourth edition of the World Health Organization Classification …

Plasmablastic lymphoma (PBL) is a distinct variant of diffuse large B-cell lymphoma initially
described in HIV-positive patients. Several studies have reported the occurrence of PBL in …

BACKGROUND: Plasmablastic lymphoma (PBL) is a rare and aggressive B‐cell lymphoma
strongly associated with human immunodeficiency virus (HIV) infection. The authors …

The contribution of Epstein-Barr virus (EBV) to the development of specific types of benign
lymphoproliferations and malignant lymphomas has been extensively studied since the …

Background Plasmablastic lymphoma (PBL), initially described in 1997 in the oral cavity of
HIV positive patients, is now recognized as a distinct aggressive and rare entity of diffuse …

Despite the introduction of highly active antiretroviral therapy or combination antiretroviral
therapy (HAART and cART, respectively) patients infected with HIV might develop certain …